US2023099559A1PendingUtilityA1
Medical devices
Est. expiryMay 12, 2037(~10.8 yrs left)· nominal 20-yr term from priority
A61L 31/08A61L 2400/18A61L 31/022A61F 2/0077A61F 2/06A61L 31/10A61F 2/82A61L 31/14
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described are medical devices including expandable tubular bodies configured to be implanted into a lumen, wherein the outer surface of the expandable tubular bodies are coupled to a polymer(s).
Claims
exact text as granted — not AI-modified1 . A medical device, including:
an outer surface coupled to a polymer prepared from the free radical polymerization of a first acrylate monomer and a second monomer including an amine, a carboxylic acid, or a hydroxyl functionality; wherein the first monomer is an alkoxyalkyl (meth)acrylate, tetrahydrofurfuryl acrylate, or an alkoxyalkyl acrylate.
2 . The medical device of claim 1 , including an expandable tubular body configured to be implanted into a blood vessel.
3 . The medical device of claim 2 , wherein the expandable tubular body includes a metal.
4 . The medical device of claim 3 , wherein the metal includes gold, silver, copper, steel, aluminum, titanium, cobalt, chromium, platinum, nickel, combinations thereof, or an alloy thereof.
5 . The medical device of claim 4 , wherein the metal is a combination of nitinol and platinum-tungsten.
6 . The medical device of claim 1 , wherein the polymer is covalently coupled to the outer surface.
7 . (canceled)
8 . The medical device of claim 1 , wherein the alkoxyalkyl acrylate has the formula
wherein
R 1 is hydrogen,
R 2 is an alkylene group with 1 to 4 carbons, and
R 3 is an alkyl group with 1 to 4 carbons.
9 . The medical device of claim 3 , wherein the metal includes nitinol (nickel-titanium), cobalt-nickel, cobalt-chromium, platinum-tungsten, or a combination thereof.
10 . (canceled)
11 . The medical device of claim 1 ,
wherein the outer surface is a silanized outer surface.
12 . The medical device of claim 1 , wherein the outer surface is a hydroxylated outer surface.
13 . (canceled)
14 . The medical device of claim 11 , wherein the outer surface is silanized to form the silanized outer surface through reaction with a silane selected from:
or a combination thereof,
wherein n is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, or 15.
15 . The medical device of claim 14 , wherein n is 8-12.
16 - 18 . (canceled)
19 . The medical device of claim 11 , wherein the first monomer is alkoxyalkyl (meth)acrylate or tetrahydrofurfuryl acrylate.
20 . The medical device of claim 11 , wherein the second monomer is acrylic acid, methacrylic acid, hydroxyethyl methacrylate, hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxybutyl acrylate, aminoethyl methacrylate, aminopropyl methacrylamide, a combination thereof.
21 . The medical device of claim 1 , wherein
the outer surface is a silanized to form a silanized outer surface through reaction with a silane, wherein the silane includes a reactive group selected from an acrylate, methacrylate, aldehyde, epoxy, ester, or a combination thereof, and the first monomer is alkoxyalkyl (meth)acrylate, tetrahydrofurfuryl acrylate, or
wherein
R 1 is hydrogen,
R 2 is an alkylene group with 1 to 4 carbons, and
R 3 is an alkyl group with 1 to 4 carbons.
22 . The medical device of claim 21 , wherein the outer surface is a hydroxylated outer surface prior to being silanized.
23 . The medical device of claim 21 , wherein the silane is selected from:
or a combination thereof.
24 . The medical device of claim 21 , wherein the first monomer is tetrahydrofurfuryl acrylate.
25 . The medical device of claim 21 , wherein the second monomer is acrylic acid, methacrylic acid, hydroxyethyl methacrylate, hydroxyethyl acrylate, hydroxypropyl acrylate, hydroxybutyl acrylate, aminoethyl methacrylate, aminopropyl methacrylamide, or a combination thereof.
26 . The medical device of claim 21 , wherein the silane includes an epoxy reactive group.
27 . The medical device of claim 21 , wherein the first monomer is alkoxyalkyl (meth)acrylate.
28 . The medical device of claim 21 , wherein the silane is selected from:
or a combination thereof.
29 . The medical device of claim 21 , wherein the second monomer is hydroxybutyl acrylate, aminopropyl methacrylamide, or a combination thereof.
30 . The medical device of claim 21 , wherein the first monomer is methoxyethyl acrylate.
31 . The medical device of claim 11 , wherein the outer surface is silanized to form the silanized outer surface through reaction with a silane, wherein the silane includes a reactive group selected from an acrylate, methacrylate, aldehyde, epoxy, ester, halogen, or combination thereof.Join the waitlist — get patent alerts
Track US2023099559A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.